Eli Lilly
Signals mentioning Eli Lilly
- Pharma-nutrition tie-ups race to capture $150B GLP-1 companion market
- Semaglutide channel chokes on Rs 100cr excess stock as April generic rush fades
- DCGI orders nationwide crackdown on illegal sildenafil, tadalafil sales across pharmacies and e-platforms